Ergoteles’s BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant BOAS.U Stock Holding History

Ergoteles’s Portfolio BOAS.U Stock Details BOAS.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-24,421	Closed	-$244K	–	2162
2022 Q3	$244K	Hold	24,421	–	–	0.01%	1083
2022 Q2	$240K	Buy	24,421 +2,621	+12%	+$26K	0.01%	1225
2022 Q1	$217K	Hold	21,800	–	–	0.01%	959
2021 Q4	$218K	Hold	21,800	–	–	0.01%	988
2021 Q3	$215K	Hold	21,800	–	–	0.01%	950
2021 Q2	$216K	Hold	21,800	–	–	﹤0.01%	1237
2021 Q1	$216K	Buy	+21,800	New	+$218K	0.01%	643

Ergoteles's BOAS.U Position: Q4 2022 in Review

Ergoteles sold out of BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant (BOAS.U) in Q4 2022, closing a stake of 24,421 shares — an estimated $244K sold.

Ergoteles first reported a position in BOAS.U in Q1 2021 and held it in 7 quarters. The position peaked at $244K in Q3 2022. 0 funds tracked by Wall St. Rank hold BOAS.U as of Q4 2022.

Ergoteles reported no remaining BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 24,421 BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant shares in Q4 2022, an estimated $244K.
Ergoteles first reported a position in BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant in Q1 2021 and held it in 7 quarters.
Ergoteles's BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant position peaked at $244K in Q3 2022.
0 funds tracked by Wall St. Rank held BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.